Scenarios and Watch List

Scenarios and Watch List

Whether the 86% fall left a genuinely mispriced business or one that is still de-rating turns on a small set of things that are measurable, dated, and mostly arrive within a year. This chapter reconciles the report's tensions and lists what to watch, without picking a winner the evidence has not yet chosen.

Sources: price and consensus target as of 2026-07-11, consensus estimates as reported; multiples derived from FY2025 reported cash flow and balance sheet [1].

The shared facts, read two ways

Each of the report's load-bearing findings is a fact both a bull and a bear accept — the disagreement is over what it means, and in every case a specific, checkable datum would settle it. That is the useful shape of the case: not competing opinions, but one set of numbers awaiting a few more prints.

At $19.53 The Trade Desk's ~$8.03B enterprise value is just 10.1x free cash flow — a 9.9% yield a reverse-DCF reads as pricing in almost no long-run growth — yet that free cash flow is doubly flattered: it adds back $490.6M of stock-based compensation (owner cash ~$305M, 26.3x EV, a 3.8% yield), and 97% of its 34% FY2025 growth was a one-year OBBBA deferred-tax swing of $244.6M that left underlying operating cash roughly flat at ~$825M versus ~$816M (Margin of Safety, Cash Conversion) [2]. Growth has stepped down for six straight quarters, from 25% in Q1 2025 to a Q2 2026 guide of about 8% — the first single-digit guided rate — and it kept falling straight through the December 2024 reorganization and the Kokai migration management blamed for the original miss (Deceleration) [3]. The take rate widened anyway, to about 21.6% from a stable 20.3%, because revenue grew 18% while the $13.4B of gross spend on the platform grew only 11% (Mix and Take Rate) [4].

Sources: valuation and cash figures, FY2025 10-K Cash Flows and Balance Sheet [5] [6]; guidance, Q1 FY2026 earnings release [7]; take rate, FY2025 10-K MD&A [8]; insider purchases per SEC Form 4 filings.

One feature runs under all five rows and narrows the range of outcomes: the balance sheet holds cash and short-term investments of about $1.30B and no drawn debt, so downside here is a question of valuation, not survival [9]. Net cash is $2.73 a share, roughly 14% of the price — a floor thin enough that this is not an asset play, but firm enough that the bear case is a lower multiple rather than a going-concern risk.

The pivot that moves the scenarios

The report's read is most sensitive to one input: the revenue growth rate, because the valuation's implied ~5% perpetual growth on owner cash is only conservative if the top line settles near the high-single to low-double digits. The six-quarter step-down is the reason that assumption is not yet demonstrated.

Source: quarterly revenue per company filings; Q2 2026 is the company's guide of at least $750M against $694.0M a year earlier [10].

Consensus expects the rate to hold near this level rather than break lower: about $3.18B of revenue in FY2026 and $3.48B in FY2027, both roughly 10% growth, with adjusted earnings near $1.85 and $2.15. But the estimates have been moving the wrong way — the FY2026 adjusted-EPS figure has been cut from about $2.07 ninety days ago to $1.85, and downward revisions have outnumbered upward ones by roughly nine to one over the past month. The market's own forecast is for stabilization; its recent behavior has been to keep trimming.

Three paths

The consensus target range — a low of $11, a mean of $24.42, a high of $38 against the $19.53 price — is a useful frame because it brackets the operating outcomes rather than betting on one. Each end corresponds to a coherent story the report has already sourced.

Sources: consensus target range and estimates as reported; operating assumptions drawn from FY2025 10-K MD&A [11] and the Q1 FY2026 earnings release [12].

The base path is where the arm's-length evidence clusters. Consensus mean and median targets sit at $24.42 and $24.50, and the founder's March 2026 open-market purchases — roughly $148M at $23.49 to $25.08 a share — landed in the same band, which is why the reset reads closer to fair than to a deep discount on owner economics. The bull path needs a print, not a story: a quarter that reaccelerates the rate rather than merely clearing a lowered bar would convert the ~10% base the valuation assumes from a hope into a demonstrated floor, and the balance-sheet quality plus the widening take rate are the evidence it could. The bear path needs the opposite — the gross-spend line, which grew just 11% against 18% revenue, is the early-warning gauge, because underlying ad volume decelerated harder than the top line and part of the reported growth was rate that need not repeat.

What to watch

Each item below is falsifiable, named to the line item and filing where it will surface, and ordered by how much it moves the read. The Q2 2026 result, due in early August 2026, carries the most decision value, because it is the first datum that tests the deceleration against management's cyclical framing after the fix is complete.

Sources: watch items drawn from the FY2025 10-K [13], the Q1 FY2026 earnings release [14], and SEC Form 4 insider filings; the $327M repurchase authorization is disclosed in the Q1 FY2026 release.

For a value and special-situation investor, the check that matters most sits at the top of the list. The reset has already cured the high-flyer problem the reader avoids, and the net cash with no debt takes bankruptcy — the reader's stated fear — close to zero. What it has not yet delivered is a margin of safety: on owner cash the price is 26.3x — a 3.8% yield for a roughly 10% grower — so on that measure the price is fair, and a fair price becomes a cheap one only if growth proves it is a floor. The next two prints, read against the ~8% guide and the gross-spend gauge, are what turn this from a business that is merely no longer expensive into one that is genuinely mispriced — or confirm that the de-rating was the market correctly repricing a slower business.